Product Catalog [{"id":"463","name":"Evaluation of Parsaclisib plus Bendamustine and Rituximab in patients with Newly Diagnosed Mantle Cell Lymphoma","price":1,"sku":"lymphoma-trial-2","brand":false,"position":1,"category":"Medicines\/Oncology\/Lymphoma"},{"id":"462","name":"Evaluation of Tafasitamab plus Rituximab and Lenalidomide in patients with Lymphoma that has stopped responding to treatment","price":1,"sku":"lymphoma-trial-3","brand":false,"position":2,"category":"Medicines\/Oncology\/Lymphoma"},{"id":"461","name":"Evaluation of Parsaclisib plus Rituximab or Obinutuzumab in patients with Lymphoma that has stopped responding to treatment","price":1,"sku":"lymphoma-trial-4","brand":false,"position":3,"category":"Medicines\/Oncology\/Lymphoma"},{"id":"460","name":"Evaluation of Tafasitamab plus Parsaclisib in patients with Non Hodgkin Lymphoma or Chronic Lymphocytic Leukemia","price":1,"sku":"lymphoma-leukemia-trial-1","brand":false,"position":4,"category":"Medicines\/Oncology\/Lymphoma"},{"id":"447","name":"Rylaze","price":1,"sku":"Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn)","brand":"Jazz Pharmaceuticals","position":5,"category":"Medicines\/Oncology\/Lymphoma"},{"id":"437","name":"Zynlonta","price":27746.55,"sku":"Zynlonta (loncastuximab tesirine-lpyl)","brand":"ADC Therapeutics","position":6,"category":"Medicines\/Oncology\/Lymphoma"},{"id":"434","name":"Xalkori","price":4927.62,"sku":"Xalkori (crizotinib)","brand":"Pfizer Limited","position":7,"category":"Medicines\/Oncology\/Lymphoma"},{"id":"416","name":"Ukoniq","price":1,"sku":"Ukoniq (umbralisib)","brand":"TG Therapeutics","position":8,"category":"Medicines\/Oncology\/Lymphoma"},{"id":"365","name":"Xpovio","price":32825,"sku":"Xpovio (selinexor)","brand":"Karyopharm","position":9,"category":"Medicines\/Oncology\/Lymphoma"}]

Lymphoma access options

View as Grid List

Items 1-12 of 21

Page
per page
Set Descending Direction